Cannabis Law Report

JUNE 4, 2021

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer and prostate cancer. PSA declines and CTC responses were clearly evident.

Data 100

Data Research and Development Clinical Trials Therapy 100

NORML

DECEMBER 3, 2019

Adult-use retail cannabis access is associated with a decline in the sales of over-the-counter (OTC) sleep aid medications, according to data published in the journal Complimentary Therapies in Medicine.

Sleep 214

Sleep Access Recreational Therapy 214

NORML

NOVEMBER 1, 2019

Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access 182

Access Patients Chronic Pain Law 182

The Cannigma

SEPTEMBER 4, 2024

But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world data collected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms. And she got what she was looking for!

Data 98

Data CBD Collective Cannabinoids 98

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. “Our billion by 2027.

Therapy 76

Therapy Data Research and Development Pharmaceutical 76

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior. About Realm of Caring.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

APRIL 17, 2023

. — Oregon lawmakers are currently considering a bill that would require licensed psilocybin providers to submit data about their client’s demographics to state health officials.

Data 52

Data Collective Therapy Patients 52

NORML

DECEMBER 6, 2019

The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine. Subjects receiving treatment reported no adverse effects.

Clinical Trials 111

Clinical Trials Patients CBD Therapy 111

Cannabis Law Report

APRIL 21, 2021

A new tool provides speed to market with novel psychedelic therapies through deeper data analytics.… … Read More.

Therapy 98

Therapy Data 98

Project CBD

FEBRUARY 27, 2023

Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.”

THC 144

THC CBD Clinical Trials Sleep 144

Veriheal

FEBRUARY 18, 2021

The university has conducted research that studied the best music to include in psychedelic therapy. Previous notions suggested that classical music to the likes of Mozart and Chopin, made the best match for psychedelic therapy but the study suggests that it may have no significant value. What is Psychedelic Therapy.

Therapy 52

Therapy Research and Development Collective Consumption 52

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, Partners with Pioneering Health Plan Administrator, Enthea, to Provide Psychedelic Therapy as Employee Healthcare Benefit. Leading US Company to Offer Employee Coverage for Ketamine Assisted Therapy to Promote Mental Health. First Ever Partnership Between Health Plan Administrator and.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

Cannabis Law Report

JULY 16, 2021

The diversified venture fund said in a statement that it is focused on tackling the growing global mental health crisis by investing in innovative psychedelic-based and adjacent therapies that are poised to shape the future of psychiatry and fields beyond. Wesana Health Holdings Inc. CSE: WESA) (OTC: DBDIF) is buying Psychedelitech Inc.,

Therapy 96

Therapy Data Patients 96

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. BUFFALO, N.Y. , Aug. Tweet this.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Medxtractor Corp.

Research and Development 105

Research and Development Data Conditions Therapy 105

StrainConnect

APRIL 23, 2019

Why Terpenes Are Vital To Your Cannabinoid Therapy. Why Terpenes Are Vital To Your Cannabinoid Therapy. Dont modify these 3 pswp__item elements, data is added later on. -->. By Rachael Maddison with Bradley Slaughter • 24 Apr, 2019. An intro to terpenes and how they work in hemp and cannabis. • 24 Apr, 2019.

Terpenes 63

Terpenes Cannabinoids Therapy Sativa 63

Veriheal

OCTOBER 20, 2021

Always consult a physician before attempting psychedelic therapy. Data from a nationally representative sample of participants have been collected since 1975 to understand drug use trends among American young adults, and noteworthy findings are published each fall. Cannabis and magic mushrooms for the win! A Magical Future.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

The Joint Blog

NOVEMBER 4, 2019

The study found that 58% of physicians agree that “medical cannabis was a legitimate medical therapy.” ” However, as noted by NORML, around half of respondents “expressed discomfort in talking to their patients about medical cannabis options, a finding that is also consistent with prior data. A majority (>?50%)

Therapy 42

Therapy Clinical Trials Conditions Patients 42

Veriheal

DECEMBER 15, 2021

Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. The post Cannabinoids May Promote a Good Night’s Sleep, Study Finds appeared first on Cannabis Central.

Sleep 98

Sleep Cannabinoids Therapy Treatment 98

Veriheal

JANUARY 16, 2024

While there is currently no cure for cerebral palsy, various interventions such as physical therapy, occupational therapy, speech therapy, medications, and, in some cases, surgery can be performed to manage its symptoms. Treatment plans are customized to each individual’s needs.

Patients 116

Patients CBD Treatment Research and Development 116

The Cannigma

AUGUST 5, 2022

2 In 2019 the FDA approved a keta m ine-based nasal spray to treat depression that does not respond to other therapies. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” Depression and psychedelics. Who could you be if you felt better?

Treatment 141

Treatment Research and Development Therapy Digestion 141

Cannabis Law Report

JULY 22, 2021

As regulations develop, the next phase of the Company’s strategy will involve the inclusion of alternative and psychedelic therapies into Levitee’s platform of traditional healthcare assets. The company’s current portfolio of assets includes Sporeo Supply and MONKE Nutraceuticals.

eCommerce 105

eCommerce Therapy Media Access 105

Cannabis Law Report

JUNE 18, 2021

Develop strong partnerships with academic centers, small companies, and translational groups to advance drug discovery projects towards transformative therapies. Minimum of 5 years of relevant industry experience in biotechnology or pharmaceutical companies demonstrating strong data mining and filtering skills. Responsibilities.

Business 104

Business Research and Development Advocacy Data 104

Cannabis Law Report

SEPTEMBER 28, 2021

The data will then be analysed to recognise trends in responses. • Participants: The survey is open to all ACT residents over 18 years. • Use of Data and Feedback: The data will be used in my ANIP thesis and possibly for future research. My ANIP host organisation (Johnathan Davis MLA’s office) may also use the data.

Therapy 52

Therapy Medicine Data Collective 52

Cannabis Law Report

JUNE 23, 2021

. “We are excited to be initiating our pilot program with Medicann in Jersey, which represents a unique, ‘ring-fenced’ environment for establishing potentially numerous studies on the efficacy of treatments using plant-based therapies. About RYAH Group, Inc. RYAH Group, Inc. Forward-Looking Statements.

Programs 100

Programs Data Events Collective 100

Greencamp

FEBRUARY 2, 2019

These medications are combined in what’s known as HAART (highly active antiretroviral therapy). Even though these pharmaceuticals slow down the progression and lessen the quantity of the virus in a patient’s body, many sufferers experience severe pain from antiretroviral therapy. Cannabis as a palliative aid for HIV patients.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Veriheal

JANUARY 4, 2021

Medicinal cannabinoid therapies are saving and changing lives for people across America and around the world. Individuals like Coltyn Turner, Alexis Bortell, and the late Charlotte Figi helped show America the power of cannabis and cannabinoid therapies, and thanks to the access we have to information today, their stories reached the masses.

Chronic Pain 105

Chronic Pain Therapy Cannabinoids Treatment 105

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

The Cannigma

FEBRUARY 2, 2021

Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

Patients 107

Patients Clinical Trials Research and Development Treatment 107

Cannabis Law Report

JUNE 12, 2021

“The data was showing that psychedelics were providing benefits to people suffering from anxiety, depression, addiction and PTSD. ” Parker helped Courtney book into the stateside clinic offering psychedelic therapy and she received five rounds of intravenous ketamine therapy. .

Therapy 81

Therapy Treatment Medicine Sleep 81

The Joint Blog

MARCH 3, 2021

The study found “significant improvements were observed” following the initiation of cannabis therapy in most patients. The study concludes by stating that “The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment.

Therapy 61

Therapy Hybrid Marijuana Research and Development 61

The Cannigma

NOVEMBER 11, 2021

Researchers analyzed the data self-reported by the 18 participants and found statistically significant differences (which adds power and confidence to the results) between the experimental conditions in many of the items and scales used. CBD alters the subjective effects of THC.

CBD 141

CBD Research and Development THC Environment 141

Veriheal

JUNE 19, 2023

All the data provided by the report are validated and trustworthy and can be used to gain the upper hand in the industry. Also, after receiving ketamine therapy, about 392 out of 537 had significantly reduced suicidal behaviors and symptoms. Why Is the Psychedelics Market Growing? It was approved by the U.S.

Therapy 111

Therapy Treatment Patients Policy 111

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 135

Advocacy Education Events Epilepsy 135

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 124

Research and Development Data THC Clinical Trials 124